Cargando…
PD-L1 expression and its clinicopathological correlation in advanced esophageal squamous cell carcinoma in a Chinese population
BACKGROUND: Programmed death ligand 1 (PD-L1) is a ligand for the inhibitory programmed cell death protein 1 (PD-1), which are targeted by several anti-PD-1 and PD-L1 drugs for a variety of human cancers. However, only a few studies have evaluated PD-L1 expression in esophageal squamous cell carcino...
Autores principales: | Rong, Lulu, Liu, Yong, Hui, Zhouguang, Zhao, Zitong, Zhang, Yueming, Wang, Bingzhi, Yuan, Yanling, Li, Wenbin, Guo, Lei, Ying, Jianming, Song, Yongmei, Wang, Luhua, Zhou, Zhongren, Xue, Liyan, Lu, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347821/ https://www.ncbi.nlm.nih.gov/pubmed/30684971 http://dx.doi.org/10.1186/s13000-019-0778-4 |
Ejemplares similares
-
HER2 expression and relevant clinicopathological features in esophageal squamous cell carcinoma in a Chinese population
por: Rong, Lulu, et al.
Publicado: (2020) -
Tumor budding and tumor‐infiltrating lymphocytes can predict prognosis in pT1b esophageal squamous cell carcinoma
por: Li, Zhuo, et al.
Publicado: (2023) -
PIK3CA Gene Mutations and Overexpression: Implications for Prognostic Biomarker and Therapeutic Target in Chinese Esophageal Squamous Cell Carcinoma
por: Wang, Lin, et al.
Publicado: (2014) -
Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma
por: Liu, Linxiu, et al.
Publicado: (2023) -
MiR-323a-3p acts as a tumor suppressor by suppressing FMR1 and predicts better esophageal squamous cell carcinoma outcome
por: Men, Yu, et al.
Publicado: (2022)